Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions

March 2, 2026 updated by: AO Foundation, AO Spine

Durability of Supplementary Rod Constructs-SuppleMentAry Rod Technique (SMART)-for Long-segment Posterior Instrumented Spinal Fusion Procedures: A Multicenter Retrospective Comparative Study With Dual-rod Constructs

This is a multicenter retrospective comparative cohort study. The index surgery for this study is primary or revision long-segment posterior thoracolumbar (TL) instrumented fusion using either a supplementary rod construct or a dual-rod construct. Eligible patients who already had index surgery, will be identified for enrollment through a review of medical records of the participating surgeons at the study sites.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This multicenter retrospective comparative cohort study will enroll 1244 patients, who underwent primary or revision long-segment posterior thoracolumbar (TL) instrumented fusion using either a supplementary rod construct or a dual-rod construct. By comparing two groups of patients, ie, patients treated with supplementary rod constructs vs dual-rod constructs, in the setting of long-segment posterior instrumented spinal fusion, this study aims to provide quality evidence regarding the benefits of supplementary rod constructs in reducing the risk of RFs and other mechanical complications. This study shall provide the first long-term clinical evidence on clinical outcome and benefit of supplementary rod constructs.

All participating surgeons will be asked to identify a time point, denoted as X, when they started using predominantly either supplementary rod constructs or dual-rod constructs for long-segment posterior TL instrumented spinal fusion. This time point X must be on or before December 31, 2020 (the last eligible date for the index surgery). Participating surgeons will be instructed to select the time point X to be as early within the collection window as feasible to maximize the available FU period.

Once the time point X is identified for a participating surgeon, medical records of patients treated by this surgeon will be reviewed to identify consecutive eligible patients with the index surgery done between the time point X and December 31, 2020, inclusive. In the case that an eligible patient had undergone several surgeries during this period, the first primary or revision of long-segment posterior TL instrumented fusion using either a supplementary rod construct or a dual-rod construct is defined as the index surgery.

Patients will then be grouped based on the rod constructs into either the supplementary rod construct group or dual-rod construct group.

The study has two FU periods:

  • The first FU period is the first 2 years after the index surgery. The primary analysis will be done using data from the first 2 years of FU.
  • The second FU period ends on December March 31, 20232024. The duration of this FU therefore ranges from 3 years and 3 months to 10 years and 3 months.

The primary study endpoint is the occurrence of the first RF within 2 years after the index surgery.

Study Type

Observational

Enrollment (Estimated)

1244

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Calgary, Canada, T2N 2T9
        • Recruiting
        • University of Calgary Spine
        • Contact:
          • Ganesh Swamy
      • Toronto, Canada, M5T 2S8
        • Recruiting
        • University of Toronto
        • Contact:
          • Stephen Lewis
        • Contact:
          • Christopher Nielsen
      • Hong Kong, China
        • Recruiting
        • Duchess of Kent Children's Hospital
        • Contact:
          • Kenny Kwan
      • Hamamatsu, Japan, 431-3192
        • Recruiting
        • Hamamatsu University School of Medicine
        • Contact:
          • Shin Oe
      • Tokyo, Japan, 113-8654
        • Recruiting
        • University of Tokyo
        • Contact:
          • So Kato, Prof
      • Barcelona, Spain, 08035
        • Recruiting
        • Hospital Vall D´Hebron
        • Contact:
    • California
      • Redwood City, California, United States, 94588
      • Sacramento, California, United States, 95819
      • San Francisco, California, United States, 94144
        • Recruiting
        • UCSF Spine Center
        • Contact:
          • Christopher Ames
    • Maryland
      • Baltimore, Maryland, United States, 21287
        • Recruiting
        • John Hopkis Hospital
        • Contact:
          • Khaled Kebaish
    • Minnesota
      • Minneapolis, Minnesota, United States, 55454
        • Recruiting
        • University of Minnesota Medical Center
        • Contact:
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Recruiting
        • Washington University in St. Louis, School of Medicine
        • Contact:
          • Brian Neuman
      • St Louis, Missouri, United States, 63310
        • Recruiting
        • Washington University in St. Louis, School of Medicine, Saint Louis, Missouri 63110
        • Contact:
          • Munish Gupta
    • New York
      • New York, New York, United States, 10032
        • Recruiting
        • Columbia University / NYP Och Spine Hospital
        • Contact:
          • Zeeshan Sardar
    • Virginia
      • Charlottesville, Virginia, United States, 22908

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent long-segment posterior thoracolumbar (TL) instrumented fusion

Description

Inclusion Criteria:

  • Age 45 years and older.
  • Patients receiving long-segment posterior TL instrumented fusion using either supplementary rod constructs or dual-rod constructs (the index surgery).

    • Long-segment is defined as the UIV at a thoracic level and the LIV at the sacrum/ilium.
    • Supplementary rod constructs are defined as: in addition to the traditional two primary rods, at least one supplementary rod (eg, accessory rods or satellite rods) is used, and at least one supplementary rod and one primary rod (ie, at least two rods) together must span multiple (≥ 2) vertebral levels. The supplementary rod constructs do not include rods connected end-to-end or side-to-side that do not bridge multiple vertebral levels.
    • The index surgery can be a primary surgery or a revision surgery.
    • The index surgery, staged or non-staged, must use posterior spinal fusion but can be in combination with other approaches such as an anterior procedure.
  • If the index surgery is a revision surgery, the primary rods must be replaced in the revision surgery, with the exception of Harrington or Luque rods which can remain in place.

    o If the Harrington or Luque rods remain in situ, they must already have the UIV at the thoracic level and the LIV at the sacrum/ilium, or an extension of the existing Harrington or Luque is performed such that the UIV is at the thoracic level and the LIV at the sacrum/ilium.

  • The index surgery was performed between January 1, 2014, and December 31, 2020, inclusive.
  • Minimum 3 months of FU after the index surgery.
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures if applicable for retrospective data analysis.

Exclusion Criteria:

  • Spinal fusion performed for acute trauma (ie, ≤ 1 year of trauma).
  • Spinal fusion performed for tumor.
  • Spinal fusion performed for infection.
  • Patients with Parkinson's Disease.
  • Patients with neuromuscular disorders.
  • Patients with spine malignancies requiring chemo- or radiation therapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
primary/revision long-segment posterior TL instrumented fusion with dual-rod constructs
The index surgery for this study is the primary or revision of long-segment posterior TL instrumented fusion using dual-rod construct.
long-segment posterior TL instrumented fusion with either supplementary rod constructs or dual-rod constructs.
primary/revision long-segment posterior TL instrumented fusion with supplementary rod constructs
The index surgery for this study is the primary or revision of long-segment posterior TL instrumented fusion using either a supplementary rod construct.
long-segment posterior TL instrumented fusion with either supplementary rod constructs or dual-rod constructs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rod fracture (RF)
Time Frame: 2 years
Incidence of rod fracture(s)
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to rod fracture
Time Frame: 2 years
Time to the first rod fracture after index surgery
2 years
Time to rod fracture
Time Frame: 10 years and 3 months
Time to the first rod fracture after index surgery
10 years and 3 months
Configurations of supplementary rod constructs
Time Frame: Baseline
Descriptions of configurations of supplementary rod constructs
Baseline
Treatment for rod fracture
Time Frame: 10 years and 3 months
Descriptions of different treatment strategies for rod fractures
10 years and 3 months
Recurrent RFs
Time Frame: 10 years and 3 months
Incidence of recurrent rod fractures
10 years and 3 months
Other mechanical failures
Time Frame: 10 years and 3 months
Other mechanical failures other than rod fractures
10 years and 3 months
Surgical complications
Time Frame: 10 years and 3 months
Selective surgical complications
10 years and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Justin S Smith, MD, PhD, Professor of Neurosurgery Chief of Spine Division, Fellowship Director University of Virginia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2025

Primary Completion (Estimated)

December 15, 2027

Study Completion (Estimated)

July 31, 2029

Study Registration Dates

First Submitted

March 20, 2024

First Submitted That Met QC Criteria

April 11, 2024

First Posted (Actual)

April 16, 2024

Study Record Updates

Last Update Posted (Actual)

March 4, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SMART

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Fusion

Clinical Trials on long-segment posterior TL instrumented fusion

Subscribe